PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-04-12 雨念 来自浙江省

    求助under editor assessment需要多久呀

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-03-06 ms3000001245664520 来自四川省

    偏重的研究方向:中药单体;单体
    经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-07-12 jjmyym 来自浙江省

    研究里用的药不是草药或者植物提取物可以投这本杂志吗?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-04-10 Dr123 来自广东省

    偏重的研究方向:代谢组学;中药复方;作用机制
    经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。

    16

    展开16条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-07-07 匿名用户

    EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-02-13 ms7000001992773197 来自河南省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。
    24.10.24submit
    24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)
    24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)
    24.12.23submit
    25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)
    25.2.9submit
    25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)
    25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)
    under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录
    再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志

    6

    展开6条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2023-05-04 ms2000000770833142 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药复方;代谢病
    经验分享:2023.02.25 submit
    2023.03.03 under editor assessment
    2023.03.09 under review
    2023.03.19 required reviews completed
    2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。
    2023.04.12 修回,提交
    2023.04.17 under editor assessment
    2023.04.18 reviewer invited
    2023.04.24 Review Complete;
    2023.04.27 之后一直处于Under Editor Assessment状态;
    我想请问一下目前这个状态,持续一周了,大概需要多久呢?

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2024-05-30 小胖子罗军 来自上海

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;天然产物小分子
    经验分享:2024.01.27投稿
    2024.05.14接收
    因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。
    说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。

    19

    展开19条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-04-22 ms8000001456519294 来自北京

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:中药药理
    经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2273013, encodeId=6f5e22e301381, content=研究里用的药不是草药或者植物提取物可以投这本杂志吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c62225457, createdName=jjmyym, createdTime=Sat Jul 12 09:18:58 CST 2025, time=2025-07-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2272339, encodeId=fb3b22e233969, content=EM系统 期刊要求补充行号 会有双行号 手稿不要删除行号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Jul 07 09:48:15 CST 2025, time=2025-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130000, encodeId=060d21300000c, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 修回,提交<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>2023.04.24 Review Complete;<br>2023.04.27 之后一直处于Under Editor Assessment状态;<br>我想请问一下目前这个状态,持续一周了,大概需要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Thu May 04 09:18:22 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;天然产物小分子<br>经验分享:2024.01.27投稿<br>2024.05.14接收<br>因为是按10分以上杂志设计的课题,因为phar research不接收中药单体,遂无奈改投phytomedicine,小修也在意料之中。<br>说下大家比较关心的几个问题:1.阳性对照,这个是编辑要求的,我们是补了个细胞实验;2.动物实验要求至少2个浓度,伦理要求比较高:3.WB要求内参和目的条带同一张膜,这个也确实是编辑的要求,但是我们的WB当时做的时候有几个目的条带和内参挨得太近,是不同膜跑的,而且WB太多,不可能再重新做,于是提供了3次的原始数据给编辑,然后诚实说了这个情况,最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2248583, encodeId=9aa02248583a1, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:天然产物药理学,已经接收<br>稿件处理很快<br>接收后很快online(三天左右)<br><br>研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。<br><br>邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。<br><br>中间碰上圣诞节和元旦,假期十几天,稿件没进度<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5995510315, createdName=ms2000000335870032, createdTime=Sat Jan 18 10:20:30 CST 2025, time=2025-01-18, status=1, ipAttribution=山东省)]
    2025-01-18 ms2000000335870032 来自山东省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:天然产物药理学,已经接收
    稿件处理很快
    接收后很快online(三天左右)

    研究审稿人和编辑要求:动物实验要有至少两个剂量的药物组; 需要阳性对照药物。

    邀请了六个审稿人,只收到两个审稿意见回复,修回后二审,required reviews completed状态两天后接收。

    中间碰上圣诞节和元旦,假期十几天,稿件没进度

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分